Laplante

New Protocol Could Push the Limits of the Pharmaceutical Industry

Retrieved on: 
Tuesday, March 1, 2022
Interdisciplinarity, Medication, Institut national de la recherche scientifique, Innovation, INRS, Natural science, Pasteur Institute, NSERC, Laplante, Administration, Toxicity, Magnetic resonance imaging, Research, MRI, Drug discovery, Institute, Nature Protocols, QC, Canada Foundation for Innovation, Solution, Engineering, NMR, Varennes-en-Argonne, Developing Solutions, Inc, Student, MONTRAL, CFI, Pharmaceutical industry, Medical imaging, Mitacs

MONTRAL and LAVAL, QC, March 1, 2022 /CNW Telbec/ - Pharmaceutical compounds can behave differently in aqueous solution.

Key Points: 
  • MONTRAL and LAVAL, QC, March 1, 2022 /CNW Telbec/ - Pharmaceutical compounds can behave differently in aqueous solution.
  • Professor Steven LaPlante of the Institut national de la recherche scientifique (INRS) has developed a protocol to monitor the solution behavior of drugs.
  • "With this protocol, pharmaceutical industries could avoid working on a compound with undesirable activity in aqueous solution at the early lead identification stages.
  • This would avoid issues and downstream waste in productivity," says Professor LaPlante, who has many years of experience in the pharmaceutical industry.

Leading Emerging Companies + Venture Capital Partners Michael Glaser and Mike LaPlante Join Morrison & Foerster in San Francisco

Retrieved on: 
Tuesday, February 1, 2022
Science and technology in Asia, Growth, Culture, University School, University, Veteran, AI, Technology, Environment, Topical steroid withdrawal, Laplante, UCLA Journal of Environmental Law and Policy, Knowledge, State university system, UCLA School of Law, Emerging, Morrison, Digital media, Professional, Lawyer, Privacy, Leadership, New York University School of Law, Morrison & Foerster, Corporate law, Woman, Financial technology, Mofo, Albany, The American Lawyer, Civil and political rights, SAN, Silicon, Commerce, Private law, Social media, ABA, Color, Employment, San Francisco Bay Area, Chambers, Cloud, IPO, University of California, Hastings College of the Law, Bar association, Formulary (model document), VC, Video game, Law

SAN FRANCISCO, Feb. 1, 2022 /PRNewswire-PRWeb/ -- Morrison & Foerster , a leading global law firm, is pleased to announce the additions of Michael Glaser and Mike LaPlante as partners in the firm's Corporate Department and Emerging Companies + Venture Capital (ECVC) Group.

Key Points: 
  • SAN FRANCISCO, Feb. 1, 2022 /PRNewswire-PRWeb/ -- Morrison & Foerster , a leading global law firm, is pleased to announce the additions of Michael Glaser and Mike LaPlante as partners in the firm's Corporate Department and Emerging Companies + Venture Capital (ECVC) Group.
  • Together, Mr. Glaser and Mr. LaPlante bring to the firm over three decades of experience and one of the largest emerging companies practices in Northern California.
  • Mr. Glaser and Mr. LaPlante join Morrison & Foerster from another leading law firm, where Mr. Glaser recently served as co-chair of the ECVC practice.
  • This includes the high-profile arrivals of San Francisco-based ECVC partners Murray Indick , co-chair of the firm's ECVC practice, and Brad Kondracki .

Odgers Berndtson Announces Recruitment of Dr. William A. LaPlante to Lead The Charles Stark Draper Laboratory

Retrieved on: 
Tuesday, September 29, 2020
Odgers, Draper, Laplante, Mitre Corporation, Science and technology awards, Occupations, Science and technology in the United States

NEW YORK, Sept. 29, 2020 /PRNewswire/ -- Odgers Berndtson, a leading global executive search firm, is pleased to announce the successful recruitment of Dr. William A. LaPlante, senior vice president at The MITRE Corporation, to lead The Charles Stark Draper Laboratory as its next president and chief executive officer.

Key Points: 
  • NEW YORK, Sept. 29, 2020 /PRNewswire/ -- Odgers Berndtson, a leading global executive search firm, is pleased to announce the successful recruitment of Dr. William A. LaPlante, senior vice president at The MITRE Corporation, to lead The Charles Stark Draper Laboratory as its next president and chief executive officer.
  • The appointment of Dr. LaPlante lays the groundwork for the next chapter of Draper under a new president and CEO.
  • For more than 50 years, Odgers Berndtson has delivered executive search, leadership assessment, and development strategies to the world's biggest and best organizations.
  • Odgers Berndtson currently has U.S. offices in Atlanta, Boston, Chicago, Dallas, Houston, Los Angeles, Minneapolis, New York, San Francisco, and Washington DC.

Adhesion Wealth™ Welcomes Jina LaPlante as Director of Support

Retrieved on: 
Thursday, September 19, 2019
Laplante, Adhesion

CHARLOTTE, N.C., Sept. 19, 2019 /PRNewswire/ --Adhesion Wealth, a Vestmark company, announces that Jina LaPlante has joined the firm as Director of Support.

Key Points: 
  • CHARLOTTE, N.C., Sept. 19, 2019 /PRNewswire/ --Adhesion Wealth, a Vestmark company, announces that Jina LaPlante has joined the firm as Director of Support.
  • In her new role, Ms. LaPlante will lead and build Adhesion Wealth's team of platform support, portfolio operations, and onboarding specialists.
  • Ms. LaPlante comes to Adhesion Wealth from Morgan Stanley, where she was a Director of Operations-Risk and Control.
  • "Adhesion Wealth is well-known in our industry for its dedication to ongoing support and seamless implementation," said Jina LaPlante, Director of Support at Adhesion Wealth.